• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chinese expert consensus on diagnosis and management of severe asthma.

作者信息

Lin Jiangtao, Yang Dong, Huang Mao, Zhang Yongming, Chen Ping, Cai Shaoxi, Liu Chuntao, Wu Changgui, Yin Kaisheng, Wang Changzheng, Zhou Xin, Su Nan

机构信息

Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China.

Department of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

出版信息

J Thorac Dis. 2018 Dec;10(12):7020-7044. doi: 10.21037/jtd.2018.11.135.

DOI:10.21037/jtd.2018.11.135
PMID:30746249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6344700/
Abstract
摘要

相似文献

1
Chinese expert consensus on diagnosis and management of severe asthma.《中国重症哮喘诊断与治疗专家共识》
J Thorac Dis. 2018 Dec;10(12):7020-7044. doi: 10.21037/jtd.2018.11.135.
2
[Expert consensus on the diagnosis, treatment and management of mild bronchial asthma in China (2023 edition)].《中国轻度支气管哮喘诊断、治疗与管理专家共识（2023年版）》
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Sep 12;46(9):880-896. doi: 10.3760/cma.j.cn112147-20230311-00126.
3
[Expert consensus on the diagnosis and treatment of chest tightness variant asthma in China].《中国胸闷变异性哮喘诊断与治疗专家共识》
Zhonghua Yi Xue Za Zhi. 2023 Sep 12;103(34):2662-2673. doi: 10.3760/cma.j.cn112137-20230704-01143.
4
[Strengthen the management of asthma in the elderly and strive to improve the prognosis of the disease].
Zhonghua Yi Xue Za Zhi. 2021 Apr 20;101(15):1047-1049. doi: 10.3760/cma.j.cn112137-20200914-0639.
5
Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.临床推荐意见：严重哮喘患者生物治疗管理——共识声明。
J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):36-43. doi: 10.18176/jiaci.0638. Epub 2020 Aug 26.
6
[Expert consensus for diagnosis and treatment of cervical spondylotic myelopathy with the integrated traditional Chinese and western medicine].[中西医结合治疗脊髓型颈椎病的专家共识]
Zhongguo Gu Shang. 2022 Aug 25;35(8):790-8. doi: 10.12200/j.issn.1003-0034.2022.08.017.
7
[Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].[中国、日本和韩国胃肠道间质瘤诊断与治疗的异同：从专家共识到合作前景]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Sep 25;22(9):812-819. doi: 10.3760/cma.j.issn.1671-0274.2019.09.003.
8
[Consensus-based approach for severe paediatric asthma in routine clinical practice].[基于共识的儿童重症哮喘常规临床实践方法]
An Pediatr (Barc). 2016 Feb;84(2):122.e1-122.e11. doi: 10.1016/j.anpedi.2015.08.015. Epub 2015 Oct 26.
9
Moving toward consensus on diagnosis and management of severe asthma in children.在儿童重度哮喘的诊断和管理方面达成共识。
Curr Med Res Opin. 2018 Mar;34(3):447-458. doi: 10.1080/03007995.2017.1400961. Epub 2017 Dec 4.
10
[Expert consensus on the diagnosis and treatment of allergic bronchopulmonary aspergillosis(2022 update)].
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Dec 12;45(12):1169-1179. doi: 10.3760/cma.j.cn112147-20220708-00579.

引用本文的文献

1
Machine learning algorithms for the clinical diagnosis of acute atypical asthma exacerbation.用于急性非典型哮喘加重期临床诊断的机器学习算法
Am J Transl Res. 2025 Apr 15;17(4):2916-2926. doi: 10.62347/YUOT5902. eCollection 2025.
2
Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial.美泊利单抗在中国重度哮喘患者中的疗效与安全性：一项III期随机双盲安慰剂对照试验
ERJ Open Res. 2024 May 20;10(3). doi: 10.1183/23120541.00750-2023. eCollection 2024 May.
3
Omalizumab for Chinese patients with moderate-to-severe allergic asthma in real-world clinical setting: a prospective, observational study.奥马珠单抗治疗中国中重度过敏性哮喘患者的真实世界临床研究：一项前瞻性、观察性研究。
BMJ Open Respir Res. 2023 Sep;10(1). doi: 10.1136/bmjresp-2022-001549.
4
Efficacy of Herbal Medicines on Lung Function in Asthma: a systematic review and meta-analysis of randomized controlled trials.草药对哮喘肺功能的疗效：一项随机对照试验的系统评价和荟萃分析
J Pharmacopuncture. 2023 Jun 30;26(2):124-138. doi: 10.3831/KPI.2023.26.2.124.
5
The randomized, single- and multiple- ascending dose studies of the safety, tolerability, pharmacokinetics of CSPCHA115 in healthy Chinese subjects.CSPCHA115 在健康中国受试者中的安全性、耐受性和药代动力学的随机、单次和多次递增剂量研究。
Clin Transl Sci. 2023 Mar;16(3):447-458. doi: 10.1111/cts.13455. Epub 2022 Dec 9.
6
Influence of sex, cigarette smoking and airway inflammation on treatable traits in CBIOPRED severe asthma.性别、吸烟及气道炎症对CBIOPRED重度哮喘可治疗特征的影响
Clin Transl Allergy. 2022 Sep 15;12(9):e12189. doi: 10.1002/clt2.12189. eCollection 2022 Sep.
7
The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma.韩国严重哮喘登记研究（KoSAR）：严重哮喘的真实世界研究。
Korean J Intern Med. 2022 Feb;37(2):249-260. doi: 10.3904/kjim.2021.403. Epub 2022 Feb 28.
8
Patients' experiences of asthma exacerbation and management: a qualitative study of severe asthma.哮喘急性加重与管理的患者体验：一项关于重度哮喘的定性研究
ERJ Open Res. 2021 Apr 6;7(2). doi: 10.1183/23120541.00528-2020. eCollection 2021 Apr.
9
Sanao decoction for asthma: Protocol of a systematic review.用于哮喘的三拗汤：一项系统评价方案
Medicine (Baltimore). 2019 May;98(18):e15313. doi: 10.1097/MD.0000000000015313.

本文引用的文献

1
[A multi-center retrospective study of clinical characteristics and hospitalization costs of patients hospitalized for asthma exacerbation in China during 2013-2014].[2013 - 2014年中国因哮喘急性加重住院患者的临床特征及住院费用多中心回顾性研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Nov 12;40(11):830-834. doi: 10.3760/cma.j.issn.1001-0939.2017.11.007.
2
Chinese consensus statement on standard procedure and perioperative management of bronchial thermoplasty.支气管热成形术标准操作及围手术期管理的中国专家共识声明
J Thorac Dis. 2017 Dec;9(12):5507-5514. doi: 10.21037/jtd.2017.12.25.
3
[Analysis of short-term respiratory adverse events in 183 bronchial thermoplasty procedures].[183例支气管热成形术短期呼吸不良事件分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Mar 12;40(3):176-181. doi: 10.3760/cma.j.issn.1001-0939.2017.03.007.
4
[A cross-section study of severe asthma in eight provinces of China].[中国八个省份重度哮喘的横断面研究]
Zhonghua Nei Ke Za Zhi. 2016 Dec 1;55(12):917-921. doi: 10.3760/cma.j.issn.0578-1426.2016.12.002.
5
[Bronchial thermoplasty in the treatment of severe asthma].[支气管热成形术治疗重度哮喘]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Mar;39(3):183-8. doi: 10.3760/cma.j.issn.1001-0939.2016.03.008.
6
[Effectiveness and safety of bronchial thermoplasty in patients with severe asthma].[支气管热成形术治疗重度哮喘患者的有效性和安全性]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Mar;39(3):177-82. doi: 10.3760/cma.j.issn.1001-0939.2016.03.007.
7
[Pay attention to study on the appropriate populations and mechanism of bronchial thermoplasty].
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Mar;39(3):161-3. doi: 10.3760/cma.j.issn.1001-0939.2016.03.001.
8
[Perioperative management of bronchial thermolpasty for asthma].
Zhonghua Jie He He Hu Xi Za Zhi. 2015 Dec;38(12):883-5.
9
[Diagnosis, evaluation and individualized treatment of severe asthma].
Zhonghua Yi Xue Za Zhi. 2015 Oct 13;95(38):3088-90.
10
Th-17 regulatory cytokines inhibit corticosteroid induced airway structural cells apoptosis.辅助性T细胞17调节性细胞因子抑制皮质类固醇诱导的气道结构细胞凋亡。
Respir Res. 2016 Jan 16;17:6. doi: 10.1186/s12931-015-0307-2.